Jin, U., Lee, S., & Safe, S. (2012). Aryl Hydrocarbon Receptor (AHR)-Active Pharmaceuticals Are Selective AHR Modulators in MDA-MB-468 and BT474 Breast Cancer Cells. The American Society for Pharmacology and Experimental Therapeutics.
Citación estilo ChicagoJin, Un-Ho, Syng-ook Lee, y Stephen Safe. Aryl Hydrocarbon Receptor (AHR)-Active Pharmaceuticals Are Selective AHR Modulators in MDA-MB-468 and BT474 Breast Cancer Cells. The American Society for Pharmacology and Experimental Therapeutics, 2012.
Cita MLAJin, Un-Ho, Syng-ook Lee, y Stephen Safe. Aryl Hydrocarbon Receptor (AHR)-Active Pharmaceuticals Are Selective AHR Modulators in MDA-MB-468 and BT474 Breast Cancer Cells. The American Society for Pharmacology and Experimental Therapeutics, 2012.